These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 35968876)

  • 61. Epidemiology of hospitalization for acute bronchiolitis in children: differences between RSV and non-RSV bronchiolitis.
    Hervás D; Reina J; Yañez A; del Valle JM; Figuerola J; Hervás JA
    Eur J Clin Microbiol Infect Dis; 2012 Aug; 31(8):1975-81. PubMed ID: 22240853
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Restricted Palivizumab Recommendations and the Impact on RSV Hospitalizations among Infants Born at > 29 Weeks of Gestational Age: An Italian Multicenter Study.
    Priante E; Tavella E; Girardi E; Militello MA; Mardegan V; Maule MM; Dall'Agnola A; Baraldi E; Manzoni P
    Am J Perinatol; 2019 Jul; 36(S 02):S77-S82. PubMed ID: 31238365
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Modeling the Potential Impact of the 2014 American Academy of Pediatrics Respiratory Syncytial Virus Prophylaxis Guidance on Preterm Infant RSV Outcomes.
    McLaurin KK; Chatterjee A; Makari D
    Infect Dis Ther; 2015 Oct; 4(4):503-11. PubMed ID: 26499122
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cost-utility analysis of Palivizumab for Respiratory Syncytial Virus infection prophylaxis in preterm infants: update based on the clinical evidence in Spain.
    Sanchez-Luna M; Burgos-Pol R; Oyagüez I; Figueras-Aloy J; Sánchez-Solís M; Martinón-Torres F; Carbonell-Estrany X
    BMC Infect Dis; 2017 Oct; 17(1):687. PubMed ID: 29041909
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Prospective population-based study of RSV-related intermediate care and intensive care unit admissions in Switzerland over a 4-year period (2001-2005).
    Berger TM; Aebi C; Duppenthaler A; Stocker M;
    Infection; 2009 Apr; 37(2):109-16. PubMed ID: 19412586
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Trends in RSV testing patterns among infants presenting with bronchiolitis: Results from four United States health systems, 2015-2023.
    Blatt AZ; Suh M; Walter EB; Wood CT; Espinosa C; Enriquez-Bruce ME; Domachowske J; Daniels D; Budhecha S; Elliott A; Wolf Z; Waddell EB; Movva N; Reichert H; Fryzek JP; Nelson CB
    Ann Epidemiol; 2024 Jun; 94():72-80. PubMed ID: 38685519
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Respiratory Syncytial Virus Is the Leading Cause of United States Infant Hospitalizations, 2009-2019: A Study of the National (Nationwide) Inpatient Sample.
    Suh M; Movva N; Jiang X; Bylsma LC; Reichert H; Fryzek JP; Nelson CB
    J Infect Dis; 2022 Aug; 226(Suppl 2):S154-S163. PubMed ID: 35968878
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Respiratory Syncytial Virus Hospitalizations among U.S. Preterm Infants Compared with Term Infants Before and After the 2014 American Academy of Pediatrics Guidance on Immunoprophylaxis: 2012-2016.
    Goldstein M; Krilov LR; Fergie J; McLaurin KK; Wade SW; Diakun D; Lenhart GM; Bloomfield A; Kong AM
    Am J Perinatol; 2018 Dec; 35(14):1433-1442. PubMed ID: 29920638
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Perinatal history and hospitalization for bronchiolitis. A comparison with the impact-RSV Study Group].
    Bonillo Perales A ; DíezDelgado Rubio J ; Ortega Montes A ; Infante Márquez P ; Jiménez Liria M ; Batlles Garrido J ; López Muñoz J
    An Esp Pediatr; 2000 Dec; 53(6):527-32. PubMed ID: 11148149
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Respiratory syncytial virus morbidity and outpatient palivizumab dosing in South Carolina, 2004-2009.
    Chadha AD; Bao W; Holloway J; Mann J; Rye AK; Brown DE
    South Med J; 2012 Aug; 105(8):399-404. PubMed ID: 22864095
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Epidemiology of respiratory syncytial virus bronchiolitis in hospitalized infants in Greece.
    Tsolia MN; Kafetzis D; Danelatou K; Astral H; Kallergi K; Spyridis P; Karpathios TE
    Eur J Epidemiol; 2003; 18(1):55-61. PubMed ID: 12705624
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Respiratory syncytial virus disease morbidity in Australian infants aged 0 to 6 months: a systematic review with narrative synthesis.
    Self A; Van Buskirk J; Clark J; Cochrane JE; Knibbs L; Cass-Verco J; Gupta L
    BMC Public Health; 2023 Dec; 23(1):2560. PubMed ID: 38129854
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Trends in respiratory syncytial virus bronchiolitis hospitalizations in children less than 1 year: 2004-2012.
    Sanchez-Luna M; Elola FJ; Fernandez-Perez C; Bernal JL; Lopez-Pineda A
    Curr Med Res Opin; 2016; 32(4):693-8. PubMed ID: 26709735
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Economic-Burden Trajectories in Commercially Insured US Infants With Respiratory Syncytial Virus Infection.
    Chirikov VV; Simões EAF; Kuznik A; Kwon Y; Botteman M
    J Infect Dis; 2020 Mar; 221(8):1244-1255. PubMed ID: 30982895
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Respiratory syncytial virus acute respiratory infection-associated hospitalizations in preterm Mexican infants: A cohort study.
    Benítez-Guerra D; Piña-Flores C; Zamora-López M; Escalante-Padrón F; Lima-Rogel V; González-Ortiz AM; Guevara-Tovar M; Bernal-Silva S; Benito-Cruz B; Castillo-Martínez F; Martínez-Rodríguez LE; Ramírez-Ojeda V; Tello-Martínez N; Lomelí-Valdez R; Salto-Quintana J; Cadena-Mota S; Noyola DE
    Influenza Other Respir Viruses; 2020 Mar; 14(2):182-188. PubMed ID: 31917902
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Palivizumab for immunoprophylaxis of respiratory syncytial virus (RSV) bronchiolitis in high-risk infants and young children: a systematic review and additional economic modelling of subgroup analyses.
    Wang D; Bayliss S; Meads C
    Health Technol Assess; 2011 Jan; 15(5):iii-iv, 1-124. PubMed ID: 21281564
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Long-term Assessment of Healthcare Utilization 5 Years After Respiratory Syncytial Virus Infection in US Infants.
    Simões EAF; Chirikov V; Botteman M; Kwon Y; Kuznik A
    J Infect Dis; 2020 Mar; 221(8):1256-1270. PubMed ID: 31165865
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Respiratory syncytial virus-related bronchiolitis in Puerto Rico.
    Molinari Such M; García I; García L; Puig G; Pedraza L; Marín J; Valcárcel M
    P R Health Sci J; 2005 Jun; 24(2):137-40. PubMed ID: 16116931
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Incidence and risk factors of hospitalisations for respiratory syncytial virus among children aged less than 2 years.
    Na'amnih W; Kassem E; Tannous S; Kagan V; Jbali A; Hanukayev E; Freimann S; Obolski U; Muhsen K
    Epidemiol Infect; 2022 Feb; 150():e45. PubMed ID: 35105415
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Recurrent wheezing after respiratory syncytial virus or non-respiratory syncytial virus bronchiolitis in infancy: a 3-year follow-up.
    Valkonen H; Waris M; Ruohola A; Ruuskanen O; Heikkinen T
    Allergy; 2009 Sep; 64(9):1359-65. PubMed ID: 19416146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.